Total amount raised
Latest funding date
Location
Ryan Spencer is the Chief Executive Officer of Dynavax Technologies, a biopharmaceutical company known for its innovative vaccines. Since his appointment in 2019, Spencer has led the company through significant milestones, including the commercial launch of HEPLISAV-B® and the global supply of the CpG 1018® adjuvant for COVID-19 vaccines. His leadership has been instrumental in establishing Dynavax as a key player in the biotech industry.
Who is the CEO of Dynavax?
Ryan Spencer, the Chief Executive Officer of Dynavax Technologies, has a robust background in the biopharmaceutical industry. Before becoming CEO in 2019, he held several key positions within Dynavax, including Interim Co-President and Senior Vice President of Commercial. His career began with roles such as Assistant Controller at QRS Corporation and a member of the audit practice at Ernst & Young.
His leadership has been pivotal in advancing Dynavax's commercial strategies and operational success.
Work History
Ryan Spencer's work history includes a variety of roles in the biopharmaceutical and financial sectors. Here is a detailed list of his previous positions:
- Dynavax Technologies - Chief Executive Officer (2019 - Present)
- Dynavax Technologies - Interim Co-President (2018 - 2019)
- Dynavax Technologies - Senior Vice President of Commercial (2017 - 2018)
- QRS Corporation - Assistant Controller (2000 - 2005)
- Ernst & Young - Member of the Audit Practice (1999 - 2000)
Education History
Ryan Spencer's educational journey laid a strong foundation for his successful career in the biopharmaceutical and financial sectors. He earned a Bachelor of Arts in Business Economics from the University of California, Santa Barbara. This academic background equipped him with the essential knowledge and skills in economics, finance, and business management, which have been pivotal in his various leadership roles at Dynavax Technologies and other companies. Spencer's education has undoubtedly played a crucial role in shaping his strategic vision and operational expertise.
When did Ryan Spencer join Dynavax?
Ryan Spencer joined Dynavax Technologies in 2005, marking the beginning of a long and impactful tenure with the company. He became the Chief Executive Officer in December 2019, a role in which he has continued to drive the company's growth and innovation. With nearly two decades at Dynavax, Spencer's extensive experience within the organization has been instrumental in his leadership and strategic vision. His educational background, including a Bachelor of Arts in Business Economics from the University of California, Santa Barbara, has provided a solid foundation for his successful career in the biopharmaceutical industry.
